InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,780.05
(
-0.21%
)
US TECH 100
19,727.60
(
0.01%
)
Dow Jones
42,454.12
(
-0.14%
)
Brent Oil
78.55
(
-0.65%
)
Bitcoin
60,620.21
(
0.58%
)
Post# of 253340
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 103554

Friday, 01/21/2011 6:28:53 AM

Friday, January 21, 2011 6:28:53 AM

Post# of 253340

Teva attempted to have three additional Copaxone patents pertaining to molecular-weight markers [Nos. 6514938, 7074580, and 7163802] included in the litigation, but this request was denied by the Court.

I heard that on the 19-Jan-2011 Mylan/Natco Markman hearing these molecular-weight markers related patents (there's another one, see link) were discussed.

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=7615359.PN.&OS=PN/7615359&RS=PN/7615359
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up